UroToday.com – In the online edition of Urology, Dr. Steven Chang and associates from the SEARCH database report that time to first detectable ultrasensitive PSA (uPSA) identifies men with low-risk recurrence prostate cancer (CaP). PSA doubling time (PSADT) 0.2ng/ml, this study determined whether measurement of changes in uPSA over time can identify men who will develop high-risk recurrent CaP as defined by a PSADT 0.2ng/ml separated by 3 or more months within 2 years of biochemical failure…

More here: 
Freedom From A Detectable Ultrasensitive Prostate-Specific Antigen At Two Years After Radical Prostatectomy Predicts A Favorable Clinical Outcome

Related posts:

1. Time Between Treatment And PSA Recurrence Predicts Death From Prostate CancerMen whose prostate specific antigen (PSA) rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by...
2. Detection Of Prostate Specific Antigen With Nanomechanical ResonatorsUroToday.com - Detection of PSA with increasing sensitivity may enhance several aspects of disease monitoring. Micro- and nanoelectromechanical systems (MEMS and NEMS) are new devices for detection of infectious agents...
3. Prostate Cancer Diagnosis And Treatment After The Introduction Of Prostate-Specific Antigen Screening: 1986-2005UroToday.com - Screening and early detection should identify cancers that will become clinically relevant. In this case, the number of individuals diagnosed with cancer would be unaffected by screening. However,...
4. Long-Term Survival In Prostate Cancer Patients Can Be Predicted By PSA Value At 2 Years Post-TreatmentProstate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to...
5. Penile Length Shortening After Radical Prostatectomy: Men’s ResponsesUroToday.com - Erectile dysfunction is the most commonly recognized side effect of radical prostatectomy (RP) for prostate cancer (CaP). However, post-surgery penile length shortening (PLS) is known to occur in...
6. Comparative Effectiveness Of Minimally Invasive Vs Open Radical ProstatectomyUroToday.com - Minimally invasive radical prostatectomy (MIRP) for prostate cancer (CaP) is the most common treatment modality for localized CaP in the United States. The popularity in part is due...
7. Biopsy Schemes With The Fewest Cores For Detecting 95% Of The Prostate Cancers Detected By A 24-Core BiopsyUroToday.com - Transrectal ultrasound with prostate biopsy (TRUS/Bx) remains the method for detection of prostate cancer (CaP) in men with an elevated PSA or abnormal digital rectal examination. It is...
8. YouTube As Source Of Prostate Cancer InformationUroToday.com - Half of patients faced with a decision related to prostate cancer (CaP) will use the Internet for information. YouTube is a popular Internet video site with over 100...
9. Study Of Race, Income And Prostate Cancer OutcomeA patient's socioeconomic status (income, marital status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new...
10. Clinical Interpretation Of The Expanded Prostate Cancer Index Composite-Short Form Sexual Summary ScoreUroToday.com - In the December, 2009 online edition of the Journal of Urology, Dr. Jeffrey Wheat and colleagues from the University of Michigan utilize the Expanded Prostate Cancer Index Composite...
11. New Finding Suggests Prostate Biopsy Is Not Always NecessaryResearchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone...
12. Risk For High-Grade Prostate Cancer May Be Reduced By Low CholesterolMen with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to...
13. Questioning The Value of Prostate Cancer ScreeningQuestion: From what I've read looks like there's some disagreement in the medical community about prostate exams. What's the scoop?...
14. Prostate Cancer Query And ReplyWhile many sicknesses and diseases are properly understood, prostate most cancers is likely one of the remaining cancerous situations that is shrouded in misunderstanding. There are a number of foremost...
15. Primary Endpoint Reached In Active Biotech’s TASQ Phase II Clinical Trial In Prostate Cancer PatientsA first analysis of the primary endpoint based on data from at least six months' treatment of more than 200 patients, has been performed in Active Biotech AB's (NASDAQ OMX...